BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:QCZ484 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of QCZ484\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07543120-11268@assetmemo.bio
DTSTAMP:20261121T005633Z
DTSTART;VALUE=DATE:20310507
DTEND;VALUE=DATE:20310508
SUMMARY:QCZ484: Phase 2 readout est. (NCT07543120)
DESCRIPTION:QCZ484\, phase 2\, Hypertension.\nStudy: An Open-label Extensio
 n Safety and Efficacy Study of QCZ484 in Hypertensive Patients.\nEstimated
  primary completion: 7 May 2031. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/qcz484#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07543120
URL:https://assetmemo.bio/drug/qcz484#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
